The Pharmacogenetics of Immunosuppression for Organ Transplantation: A Route to Individualization of Drug Administration

Author： Fredericks S.  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.3, Iss.5, 2003-01, pp. : 291-301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?

By MacPhee Iain AM   Fredericks Salim   Holt David W  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2593-2605

Informa Healthcare

Access to resources Recommend Favorite

Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation

By Szekeres Thomas   Haushofer Alexander  

Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. : 163-168

Future Medicine

Access to resources Recommend Favorite

Adverse Effects of Immunosuppression in Pediatric Solid Organ Transplantation

By Schonder Kristine S.   Mazariegos George V.   Weber Robert J.  

Pediatric Drugs, Vol. 12, Iss. 1, 2010-02 ,pp. : 35-49

Adis International

Access to resources Recommend Favorite

Pharmacogenetics for the Individualization of Psychiatric Treatment

By Arranz M.J.   Collier D.   Kerwin R.W.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 1, 2001-01 ,pp. : 3-10

Adis International

Access to resources Recommend Favorite

Effect of drug administration route on QOL, LOS in COPD

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite